FDA Recall Open, Classified

Immunoassay Premium Control Tri Level-In vitro diagnostic use, as assayed quality control material to monitor the accuracy and reproducibility of analytes Catalog Number: IA2633

Recall: Z-2022-2023 · Initiated May 4, 2023

Recall

Recall Number
Z-2022-2023
Event Number
92344
Firm
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
FEI Number
1000361607
Product Code
JJY
Status
Open, Classified
Root Cause
Nonconforming Material/Component
Initiated
May 4, 2023
Posted
June 28, 2023

Description

Immunoassay Premium Control Tri Level-In vitro diagnostic use, as assayed quality control material to monitor the accuracy and reproducibility of analytes Catalog Number: IA2633

Reason

Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control Tri Level kit batch 583135 lot 2031EC has been reassigned on the Roche Cobas e801 due to High recovery outside range

Action

Randox issued via email to the Distributor Medical Device Correction Letter and forwarded to US and PR customers on 04 May, 2023. Letter states reason for recall, health risk and action to take: Discontinue use of and discard the current IFU and download the updated IFU from randox.com Discuss the contents of this notice with your Medical Director. Complete and return the response for 12187-QA to [email protected] within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organization. If you have any questions or concerns please contact Randox Technical Services.

Distribution

CA, IL, VA, WA, WI including PR

Quantity

30 kits